The present invention generally relates to various polymer solid electrolyte materials suitable for various electrochemical devices and methods for making or using the same. Certain embodiments of the invention are generally directed to solid electrolytes having relatively high ionic conductivity and/or other mechanical or electrical properties, e.g., tensile strength or decomposition potential. Certain aspects include a polymer, a plasticizer, and an electrolyte salt. In some cases, the polymer may exhibit certain structures such as:

##STR00001##

where R.sub.1 can be one of the following groups:

##STR00002##

where n is an integer between 1 and 10000, m is a integer between 1 and 5000, and R.sub.2 to R.sub.6 can each independently be one of the following structures:

##STR00003##

Disclosed are a spiral coated stent with controllable gradient degradation, a preparation method thereof and an application thereof. The spiral coated stent with controllable gradient degradation is composed of a degradable medical polyurethane and a degradable magnesium alloy material, wherein the degradable medical polyurethane contains a following chemical structure: PCL-PEG-PCL, wherein a molecular weight of the PEG is 200 to 1,000 and the molecular weight of the PCL is 200 to 10,000, and the degradable magnesium alloy material is of a spiral stent structure; and physical properties of the spiral coated stent with controllable gradient degradation need to satisfy the following technical parameters that: a breaking strength needs to be no less than 1 N, a pressure resistance needs to be no less than 2 N, and a degradation characteristic of the magnesium alloy after surface treatment shows gradient degradation with different time.

A tissue adhesive composition comprises a biodegradable adhesive; nanoparticles; and a tissue regenerative agent. Methods of adhering tissue comprise applying a film of the tissue adhesive composition to a first surface of a first biological tissue; contacting a second surface of a second biological tissue with the first surface of the first biological tissue, wherein the film of the composition is positioned between and in contact with both the first surface and the second surface.

According to an embodiment of the present invention, provided are hollow particles which have a wall portion containing polyurethane or polyurea, have an internal porous structure, and have a plurality of opening spaces blocked by the wall portion in an outermost portion of the porous structure, and a manufacturing method thereof, and a pore forming material, particles for cosmetics, and a weight reducing material.

The present invention relates to a mixture (M) which can be used as curing agent and as adhesion promoter and which comprises at least two components (M1) and (M2), which are different from one another and have in each case independently of one another free and/or blocked isocyanate groups, and which optionally comprises a further component (M3) different from (M1) and (M2); component (M1) comprises at least one aliphatic polyisocyanate, and component (M2) comprises at least one aliphatic polyisocyanate having polyether units, wherein the relative weight ratio of (M1) and (M2) in (M) to one another is in a range from 25:1 to 3:1, based in each case on the solids content of (M1) and (M2), and at least one of the components (M1), (M2), and optionally (M3) present in (M) has hydrolyzable silane groups, to a use of (M) as curing agent and adhesion promoter in a coating composition, to such a coating composition, and to methods for at least partly coating a substrate with a surfacer coat and for at least partly coating a substrate with a multicoat paint system.

The present invention relates to chain extenders, processes for their preparation and their use in the preparation of biocompatible biodegradable polyurethanes and polyurethane ureas for biomedical applications such as stents, scaffolds for tissue engineering. The chain extenders comprise a compound of formula (I) ##STR00001##

Provided is a molded body of a resin composition, which has improved easy wiping-off properties and scratch resistance. This resin composition contains (1) a thermoplastic resin and (2) a fluorine-containing copolymer; and the fluorine-containing copolymer (2) is a copolymer which comprises (a) a repeating unit formed from a fluorine-containing monomer represented by formula CH.sub.2C(X)C(O)YZRf, and (b) a repeating unit formed from a non-fluorine monomer having a hydrocarbon group with 14 or more carbon atoms, and which has a weight average molecular weight of 2,500-20,000.

The present invention provides a method for preparing hydrophilic polymer foam. The method comprises a step of providing an isocyanate functionalized prepolymer (A) and a step of foaming and curing the prepolymer (A). The prepolymer (A) is prepared by reacting diisocyanate (A1) and polyether polyol (A2), wherein the diisocyanate (A1) is selected from any one and a combination of 1,4-butyl diisocyanate (BDI), lysine diisocyanate (LDI) and 1,5-pentyl diisocyanate (PDI); the polyether polyol (A2) is a copolymer of ethylene oxide (EO) and propylene oxide (PO) and/or butylene oxide (BO); the ethylene oxide has a weight percentage of about 50%-100% in the polyether polyol, and has an OH functionality degree of 3-6, a hydroxyl value of about 21 mg KOH/g-168 mg KOH/g and a number-average molecular weight of about 1000 g/mol to about 8000 g/mol; and NCO content in the prepolymer (A) is 1%-10%.

Polymers suitable for forming carbon nanotube-functionalized reverse thermal gel compositions, compositions including the polymers, and methods of forming and using the polymers and compositions are disclosed. The compositions have reverse thermal gelling properties and transform from a liquid/solution to a gele.g., near or below body temperature. The polymers and compositions can be injected into or proximate an area in need of treatment.

The present invention relates to the discovery of new class of hydrolysable amino acid derivatives and absorbable polyester amides, polyamides, polyepoxides, polyureas and polyurethanes prepared therefrom. The resultant absorbable polymers are useful for drug delivery, tissue engineering, tissue adhesives, adhesion prevention, bone wax formulations, medical device coatings, stents, stent coatings, highly porous foams, reticulated foams, wound care, cardiovascular applications, orthopedic devices, surface modifying agents and other implantable medical devices. In addition, these absorbable polymers should have a controlled degradation profile.